Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
MOREPENLAB.NSthis companyMorepen Laboratories Limited	₹99.15	21.5×	1.64×	1.13×	12.61×	-82.7%	37.8%	4.9%	5.3%	7.6%	4.7%	-7.1%	0.17×	0.8×	5.43×	2.37×	0.5%	5	5.38	3	B
AARTIDRUGS.NSAarti Drugs Limited	₹499.75	14.97×	1.88×	1.14×	11.19×	-76.9%	29.2%	9.4%	7.6%	12.6%	10.1%	1.7%	0.37×	1.82×	7.19×	1.59×	0.6%	4	3.46	2	C
AKUMS.NSAkums Drugs & Pharmaceuticals Ltd.	₹765.85	27.96×	2.15×	1.64×	10.95×	-35.7%	21.5%	8.4%	5.9%	7.7%	5.6%	13.7%	0.05×	-0.36×	3.91×	3.25×	0.0%	—	—	2	C
ALPA.NSAlpa Laboratories Limited	₹56.58	6.52×	0.52×	0.92×	5.12×	43.1%	12.9%	1.1%	14.2%	8.1%	0.6%	8.7%	0.01×	-0.02×	4.64×	4.01×	0.0%	5	—	2	B-
BALPHARMA.NSBal Pharma Limited	₹83.18	15.3×	1.17×	0.31×	7.34×	72.1%	24.4%	6.7%	2.0%	7.6%	8.2%	-4.2%	1.94×	4.5×	1.24×	1.05×	2.0%	2	—	2	C+
GRANULES.NSGranules India Limited	₹799.20	25.35×	2.97×	2.81×	13.13×	-42.2%	43.0%	16.6%	11.1%	11.7%	10.1%	0.8%	0.3×	0.52×	7.77×	1.8×	0.2%	5	—	2	C+
Peer median	—	15.3×	1.88×	1.14×	10.95×	-35.7%	24.4%	8.4%	7.6%	8.1%	8.2%	1.7%	0.3×	0.52×	4.64×	1.8×	0.2%	5	3.46	2	—